Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Retrophin Inc (NASDAQ:RTRX)

31.74
Delayed Data
As of Jul 31
 -0.43 / -1.34%
Today’s Change
7.85
Today|||52-Week Range
36.46
+159.31%
Year-to-Date
No recent news for Retrophin Inc.

Today’s Trading

Previous close32.17
Today’s open32.21
Day’s range31.59 - 32.96
Volume226,707
Average volume (3 months)500,591
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-86.13%
Earnings growth (this year)+146.77%
Earnings growth (next 5 years)+32.00%
Revenue growth (last year)--
P/E ratio191.2
Price/Sales10.87
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BCRXBioCryst Pharmaceuti...+0.14+0.91%
ADAPAdaptimmune Therapeu...-0.05-0.33%
CHRSCoherus Biosciences ...+1.36+4.03%
AXONAxovant Sciences Ltd-0.59-4.04%
Data as of 4:01pm ET, 07/31/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.42
Annual revenue (last year)$28.2M
Annual profit (last year)-$110.9M
Net profit margin-393.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Stephen J. Aselage
Chief Financial Officer &
Senior Vice President
Laura M. Clague
Corporate headquarters
San Diego, California

Forecasts